Stay updated with breaking news from Antiviral Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
The new center will develop antivirals that could combat future pandemic-level viruses.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.
BOSTON, May 18, 2022 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration with the National